These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8720350)

  • 1. [Current orientation on medical therapy of Crohn disease].
    Grassi M; Raffa S; Damiani VC; Gurgo AM; Messini F
    Clin Ter; 1995 Nov; 146(11):737-45. PubMed ID: 8720350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and clinical features of Spanish patients with Crohn's disease. Spanish Epidemiological and Economic Study Group on Crohn's disease.
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1121-7. PubMed ID: 10524641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug safety in Crohn's disease therapy.
    Juillerat P; Pittet V; Felley C; Mottet C; Froehlich F; Vader JP; Gonvers JJ; Michetti P
    Digestion; 2007; 76(2):161-8. PubMed ID: 18239408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Crohn's disease--a practical approach.
    Knutson D; Greenberg G; Cronau H
    Am Fam Physician; 2003 Aug; 68(4):707-14. PubMed ID: 12952387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical mangement of Crohn's disease (author's transl)].
    Preel JL; Eugene C; Mignon M; Weissman A; Hardouin JP; Debray C
    Sem Hop; 1979 Mar 18-25; 55(1112):567-73. PubMed ID: 224473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Follow up of Crohn's disease under therapy with hydro-MRI].
    Ganten M; Encke J; Flosdorff P; Grüber-Hoffmann B; Erb G; Hansmann J
    Radiologe; 2003 Jan; 43(1):26-33. PubMed ID: 12552372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic therapy of Crohn's disease and ulcerative colitis].
    Banai J
    Orv Hetil; 2000 May; 141(22):1171-7. PubMed ID: 10853345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of inflammatory bowel disease in adults.
    Katz JA
    J Dig Dis; 2007 May; 8(2):65-71. PubMed ID: 17532817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ; Sandborn WJ; Tremaine WJ
    Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
    Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF
    Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment of Crohn's disease. Controlled trials.
    Van Maele P; Willocx R
    Ann Gastroenterol Hepatol (Paris); 1985; 21(4):221-6. PubMed ID: 2866752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Vermeire S; van Assche G; Rutgeerts P
    Aliment Pharmacol Ther; 2007 Jan; 25(1):3-12. PubMed ID: 17229216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history].
    Nos P; Argüello L; Hoyos M; Ramírez JJ; Hinojosa J; Molés JR; García A; Berenguer M; Berenguer J
    Rev Esp Enferm Dig; 1996 Jul; 88(7):470-4. PubMed ID: 8924324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of inflammatory bowel disease.
    Botoman VA; Bonner GF; Botoman DA
    Am Fam Physician; 1998 Jan; 57(1):57-68, 71-2. PubMed ID: 9447214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild-to-moderate active luminal Crohn's disease.
    Michetti P; Juillerat P; Mottet C; Pittet V; Gonvers JJ; Vader JP; Froehlich F; Felley C
    Digestion; 2007; 76(2):92-8. PubMed ID: 18239399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incidence and prevalence of inflammatory bowel disease in Gijon, Asturias, Spain].
    Saro Gismera C; Lacort Fernández M; Argüelles Fernández G; Antón Magarzo J; García López R; Navascues CA; Suárez González A; Díaz Alvarez G; González Bernal A; Palacios Galán A; Altadill Arregui A; Vizoso F
    Gastroenterol Hepatol; 2000; 23(7):322-7. PubMed ID: 11002532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of chronic inflammatory bowel diseases].
    Beglinger C
    Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.